XenoGesis Limited | 1,402 followers on LinkedIn. Pre-clinical DMPK and bioanalysis | When identifying problems is not enough.... XenoGesis is a laboratory-based contract research organisation (CRO) specialised in preclinical drug metabolism & pharmacokinetics (DMPK), quantitative bioanalysis and expert interpretation. The core XenoGesis team has an enviable track record of delivery in drug discovery.
View Top Employees from XenoGesis LimitedWebsite | http://www.xenogesis.com |
Revenue | $4 million |
Employees | 16 (5 on RocketReach) |
Founded | 2011 |
Address | Pennyfoot St, Nottingham, Nottinghamshire NG1 1GF, GB |
Phone | +44 115 837 0626 |
Technologies |
JavaScript,
HTML,
Twitter
+6 more
(view full list)
|
Category | Pharmaceuticals, Medical Testing & Clinical Laboratories, Biotechnology, Preclinical in vitro and in vivo DMPK, Research, Healthcare, Science and Engineering, Pharmacokinetics, ADME, PK/PD, Drug Discovery Consultancy, DMPK |
Web Rank | 18 Million |
Keywords | kinetic solubility, lipophilic spot, drugs that have aqueous solubility, logd7.4 tox, logd7.4 |
Competitors | CareerBoard, LLC, Eurofins Advinus, ISIS Services, LLC, PharmOptimaâ„¢, Plato BioPharma, Inc. |
SIC | 873, 87 |
NAICS | 54, 541, 5417 |
Looking for a particular XenoGesis Limited employee's phone or email?
The XenoGesis Limited annual revenue was $4 million in 2023.
5 people are employed at XenoGesis Limited.
XenoGesis Limited is based in Nottingham, Nottinghamshire.
The NAICS codes for XenoGesis Limited are [54, 541, 5417].
The SIC codes for XenoGesis Limited are [873, 87].